FDA Warns Consumers About Adverse Events Associated with Limbrel, a Dietary Supplement
date:Dec 07, 2017
The FDA is alerting consumers about potentially life-threatening health problems linked to Limbrel, a dietary supplement that is marketed to manage the metabolic processes associated with osteoarthritis. The company is not removing the product from the market. This product is marketed as a medical food, but the FDAs investigation determined that it is an unapproved new drug. And the FDA does not have mandatory recall authority over drug products.

The FDA is reminding consumers not to use Limbre

04/26 04:47